**Abstract**

The limitations of current pharmacotherapies for depression highlight the need for rapid acting antidepressants. The glutamate mechanisms in major depressive disorder have attracted much attention in recent years as a promising target for developing novel antidepressants. NR2A- and NR2B-containing NMDA receptors are considered as the major isoforms of functional NMDA receptor channels in CNS neurons. Death-associated protein kinase 1 (DAPK1) couples NR2B subunits at extrasynaptic sites to regulate the NMDA receptor channel conductance. However, still unknown is the involvement of DAPK1 and NR2B subunit interaction in the rapid antidepressant effect. Here we found high glutamate abundance accompanied by high expression of DAPK1, *p*-NR2B at Ser1303 and low expression of *p*-CREB, BDNF and synaptic proteins in the medial prefrontal cortex of rats that were subjected to chronic unpredictable mild stress (CUS). Blockade of astrocytic glutamate transporter-1 in the mPFC is sufficient to induce depression-like behavior and cause similar molecular changes. Administration of DAPK1 inhibitor and selective NR2B antagonist but not NR2A antagonist produced a rapid antidepressant effect. Uncoupling DAPK1 from NR2B subunit by application of cell membrane permeable Tat-NR2B~CT~ peptide also produced a rapid antidepressant effect by reducing the immobility in the forced swim test and reversing CUS-induced decrease in sucrose preference. Moreover, we found that selective NR2B antagonist did not produce rewarding effect measured with conditioned place preference paradigm. Together, our findings suggest that DAPK1 interaction with NMDA receptor NR2B subunit acts as a critical component in the rapid antidepressant actions.
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